UIH(SH:688271) Sou Hu Cai Jing·2025-12-08 11:57Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a decline in price and significant net outflow of funds, indicating potential investor concerns despite strong financial performance in recent quarters [1][2]. Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main revenue of 8.859 billion yuan, a year-on-year increase of 27.39% [3] - The net profit attributable to shareholders was 1.12 billion yuan, up 66.91% year-on-year [3] - The third quarter alone saw a main revenue of 2.843 billion yuan, representing a 75.41% increase year-on-year, with a net profit of 122 million yuan, up 143.8% [3] - The company’s gross margin stands at 47.02% [3] Market Position - United Imaging Healthcare has a total market capitalization of 106.91 billion yuan, ranking second in the medical device industry [3] - The company’s net assets are 20.805 billion yuan, ranking third in the industry [3] - The price-to-earnings ratio (P/E) is 71.58, which is higher than the industry average of 65.06 [3] - The return on equity (ROE) is 5.5%, significantly above the industry average of 0.15% [3] Fund Flow Analysis - On December 8, 2025, the stock price closed at 129.72 yuan, down 0.68%, with a total trading volume of 34,300 hands and a transaction amount of 444.5 million yuan [1] - The net outflow of main funds was 26.99 million yuan, accounting for 6.06% of the total transaction amount [1][2] - Retail investors showed a net inflow of 10.97 million yuan, indicating some level of interest from smaller investors [1][2] Institutional Ratings - In the last 90 days, 25 institutions have rated the stock, with 18 buy ratings and 7 hold ratings [4] - The average target price set by institutions over the past 90 days is 173.12 yuan [4]